首页 > 最新文献

Giornale di Clinica Nefrologica e Dialisi最新文献

英文 中文
Protocollo per la puntura a occhiello: dal passato una nuova tecnica 针刺协议:一种新技术
Pub Date : 2022-11-08 DOI: 10.33393/gcnd.2022.2503
M. Canzi, Anna Grizzo
Introduction. The Buttonhole technique described in the 1970s, and not further explored, may represent a valid alternative for the management of arteriovenous fistula; the limitations which caused the decline of this technique were high incidence of infections compared to the rope ladder or constant site techniques.Methods and Results. Creating a protocol to allow nursing training and uniformity of action in order to minimize the risk of infection and to benefit from the positive outcomes resulting from this technique. In Centers where BH was never performed we suggest to establish a small pilot group to experiment BH technique, first selecting patients with easily prickable fistulas, to minimize negative outcomes; when operators have reached a good level of dexterity and safety, the entire nursing team may be trained. Subsequently the pilot group will include more complex patients and gradually increase the number of patients suitable for BH; data collection and monitoring will allow continuous verification of the good progress of the project.Conclusions. BH technique can represent the most appropriate solution especially for difficult venipuncture cases and for the implementation of self venipuncture in home dialysis.
介绍。纽扣孔技术在20世纪70年代被描述,并没有进一步探索,可能是治疗动静脉瘘的有效选择;与绳梯或固定位置技术相比,该技术的局限性是感染发生率高。方法与结果。制定护理培训和统一行动方案,以最大限度地减少感染风险,并从该技术产生的积极结果中受益。在从未进行过BH的中心,我们建议建立一个小型试点小组来试验BH技术,首先选择容易刺痛的瘘管患者,以尽量减少负面结果;当操作人员达到良好的灵巧和安全水平时,整个护理团队可以接受培训。随后,试点群体将包括更多复杂的患者,并逐渐增加适合BH的患者数量;数据收集和监测将使项目的良好进展得到持续验证。特别是对于静脉穿刺困难的病例和在家庭透析中实施自我静脉穿刺,BH技术是最合适的解决方案。
{"title":"Protocollo per la puntura a occhiello: dal passato una nuova tecnica","authors":"M. Canzi, Anna Grizzo","doi":"10.33393/gcnd.2022.2503","DOIUrl":"https://doi.org/10.33393/gcnd.2022.2503","url":null,"abstract":"Introduction. The Buttonhole technique described in the 1970s, and not further explored, may represent a valid alternative for the management of arteriovenous fistula; the limitations which caused the decline of this technique were high incidence of infections compared to the rope ladder or constant site techniques.\u0000Methods and Results. Creating a protocol to allow nursing training and uniformity of action in order to minimize the risk of infection and to benefit from the positive outcomes resulting from this technique. In Centers where BH was never performed we suggest to establish a small pilot group to experiment BH technique, first selecting patients with easily prickable fistulas, to minimize negative outcomes; when operators have reached a good level of dexterity and safety, the entire nursing team may be trained. Subsequently the pilot group will include more complex patients and gradually increase the number of patients suitable for BH; data collection and monitoring will allow continuous verification of the good progress of the project.\u0000Conclusions. BH technique can represent the most appropriate solution especially for difficult venipuncture cases and for the implementation of self venipuncture in home dialysis.","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"93 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80289747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ruolo dell’Infermiere di Famiglia e di Comunità nell’assistenza dei pazienti in dialisi domiciliare e possibili effetti sugli outcome assistenziali 家庭和社区护士在协助在家透析病人方面的作用以及对门诊病人可能产生的影响
Pub Date : 2022-11-07 DOI: 10.33393/gcnd.2022.2478
Francesco Burrai, Margherita Gambella, Valentina Micheluzzi
From the analysis of the national and international literature and considering the socio-demographic changes, it is necessary to rethink the organizational models capable of giving concrete answers to the new health and welfare needs of the population. The progressive increase of the elderly population and of people with at least one chronic disease and the SARS-CoV-2 pandemic have highlighted the need for a health and social system close to the population, which increases the territorial assistance, in particular at the patient’s home. Home care must become an elective place for prevention and health promotion activities. PNRR funds for proximity networks, telemedicine and innovation in the health field will enable assistance to be directed towards a new organizational and operational perspective, where the family and community nurse will play a key role. In the care of patients on home dialysis the evidence described in the literature reports the benefits of home hemodialysis treatment, in which the nurse of the family and community through his care skills, technical and psychological counselling, tele assistance and e-health can be integrated into the home care path, assisting the patient and the family unit and supporting them in the different health needs, especially in the quality of life outcome.
根据对国家和国际文献的分析,并考虑到社会人口变化,有必要重新考虑能够对人口的新的保健和福利需要提供具体答案的组织模式。老年人口和至少患有一种慢性病的人的逐渐增加,以及SARS-CoV-2大流行,突出表明需要建立一个接近人口的卫生和社会系统,这增加了地域援助,特别是在患者家中。家庭护理必须成为预防和促进健康活动的选择性场所。《规划纲要》为近距离网络、远程医疗和保健领域创新提供的资金将使援助面向新的组织和业务角度,家庭和社区护士将在其中发挥关键作用。在对家庭透析患者的护理方面,文献中描述的证据报告了家庭血液透析治疗的好处,其中家庭和社区的护士可以通过其护理技能、技术和心理咨询、远程援助和电子保健纳入家庭护理路径,协助患者和家庭单位并支持他们满足不同的健康需求,特别是在提高生活质量方面。
{"title":"Ruolo dell’Infermiere di Famiglia e di Comunità nell’assistenza dei pazienti in dialisi domiciliare e possibili effetti sugli outcome assistenziali","authors":"Francesco Burrai, Margherita Gambella, Valentina Micheluzzi","doi":"10.33393/gcnd.2022.2478","DOIUrl":"https://doi.org/10.33393/gcnd.2022.2478","url":null,"abstract":"From the analysis of the national and international literature and considering the socio-demographic changes, it is necessary to rethink the organizational models capable of giving concrete answers to the new health and welfare needs of the population. The progressive increase of the elderly population and of people with at least one chronic disease and the SARS-CoV-2 pandemic have highlighted the need for a health and social system close to the population, which increases the territorial assistance, in particular at the patient’s home. Home care must become an elective place for prevention and health promotion activities. PNRR funds for proximity networks, telemedicine and innovation in the health field will enable assistance to be directed towards a new organizational and operational perspective, where the family and community nurse will play a key role. In the care of patients on home dialysis the evidence described in the literature reports the benefits of home hemodialysis treatment, in which the nurse of the family and community through his care skills, technical and psychological counselling, tele assistance and e-health can be integrated into the home care path, assisting the patient and the family unit and supporting them in the different health needs, especially in the quality of life outcome.","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75843371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
… #insiemesipuò# ... # insiemesipuò#
Pub Date : 2022-09-30 DOI: 10.33393/gcnd.2022.2444
Luisa Sternfeld Pavia
{"title":"… #insiemesipuò#","authors":"Luisa Sternfeld Pavia","doi":"10.33393/gcnd.2022.2444","DOIUrl":"https://doi.org/10.33393/gcnd.2022.2444","url":null,"abstract":"","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77250158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Possiamo fare un passo avanti verso l’ignoto e immaginare che sarà stupendo 我们可以向前迈出一步,想象这将是多么美妙
Pub Date : 2022-09-30 DOI: 10.33393/gcnd.2022.2443
Luisa Sternfeld Pavia
{"title":"Possiamo fare un passo avanti verso l’ignoto e immaginare che sarà stupendo","authors":"Luisa Sternfeld Pavia","doi":"10.33393/gcnd.2022.2443","DOIUrl":"https://doi.org/10.33393/gcnd.2022.2443","url":null,"abstract":"","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83785870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approccio nutrizionale all’ipofosforemia post-trapianto di rene: uno studio pilota 肾脏移植后低磷血症的营养方法:一项试点研究
Pub Date : 2022-09-14 DOI: 10.33393/gcnd.2022.2472
Alessandra Zattarin, Francesco Francini-Pesenti, Claudia Da Col, P. Spinella, M. Alessi, Lucia Federica Stefanelli, L. Calò
Renal transplantation is the gold standard for the treatment of ESRD patients. During the early-stage post-transplantation, metabolic and electrolytic alterations may develop, including hypophosphatemia and the treatment includes a diet rich in phosphorus, sometimes with the addition of oral or intravenous phosphorus supplement. Forty-four kidney transplanted patients with hypophosphatemia were evaluated retrospectively. They were divided into two groups based on whether patients received (group A, 14 patients) or not (group B, 30 patients) dietary prescription for hypophosphatemia. Group A was further divided into two subgroups: group A1 (8 patients), with baseline phosphatemia ≥0.5 mmol/L, treated only with a diet rich in animal phosphorus, and group A2 (6 patients), with baseline phosphatemia ≤0.5 mmol/L, who received a potassium phosphate supplement in addition to the same dietary prescription. Three months after transplantation, group A had a greater increase of phosphatemia compared with group B (group A: 0.58 ± 0.12 vs 0.93 ± 0.22 mmol/L; group B: 0.59 ± 0.11 to 0.8 ± 0.13 mmol/L). Furthermore, in group A2 the increase of phosphatemia was lower than in group A1.In conclusion, dietary approach supported by dietary counseling was effective in treating post kidney transplantation hypophosphatemia. The results of this pilot study might represent a useful working hypothesis for studies with a larger cohort of enrolled patients in order to confirm for these patients the efficacy of the nutritional approach and of the dietary counseling to post renal transplantation hypophosphatemia.
肾移植是治疗ESRD患者的金标准。在移植后早期,代谢和电解质可能发生改变,包括低磷血症,治疗包括富含磷的饮食,有时添加口服或静脉补磷。对44例低磷血症肾移植患者进行回顾性评价。根据患者是否接受低磷血症饮食处方(A组,14例)和未接受低磷血症饮食处方(B组,30例)分为两组。A组进一步分为2个亚组:A1组(8例),基线磷血症≥0.5 mmol/L,仅采用富含动物磷的饮食治疗;A2组(6例),基线磷血症≤0.5 mmol/L,在相同的饮食处方基础上补充磷酸钾。移植后3个月,A组的血磷水平明显高于B组(A组:0.58±0.12 vs 0.93±0.22 mmol/L;B组:0.59±0.11 ~ 0.8±0.13 mmol/L)。此外,A2组的磷血症升高幅度低于A1组。综上所述,饮食咨询支持的饮食方法是治疗肾移植后低磷血症的有效方法。这项初步研究的结果可能代表了一个有用的工作假设,用于研究更大的入选患者队列,以确认这些患者的营养方法和饮食咨询对肾移植后低磷血症的疗效。
{"title":"Approccio nutrizionale all’ipofosforemia post-trapianto di rene: uno studio pilota","authors":"Alessandra Zattarin, Francesco Francini-Pesenti, Claudia Da Col, P. Spinella, M. Alessi, Lucia Federica Stefanelli, L. Calò","doi":"10.33393/gcnd.2022.2472","DOIUrl":"https://doi.org/10.33393/gcnd.2022.2472","url":null,"abstract":"Renal transplantation is the gold standard for the treatment of ESRD patients. During the early-stage post-transplantation, metabolic and electrolytic alterations may develop, including hypophosphatemia and the treatment includes a diet rich in phosphorus, sometimes with the addition of oral or intravenous phosphorus supplement. Forty-four kidney transplanted patients with hypophosphatemia were evaluated retrospectively. They were divided into two groups based on whether patients received (group A, 14 patients) or not (group B, 30 patients) dietary prescription for hypophosphatemia. Group A was further divided into two subgroups: group A1 (8 patients), with baseline phosphatemia ≥0.5 mmol/L, treated only with a diet rich in animal phosphorus, and group A2 (6 patients), with baseline phosphatemia ≤0.5 mmol/L, who received a potassium phosphate supplement in addition to the same dietary prescription. Three months after transplantation, group A had a greater increase of phosphatemia compared with group B (group A: 0.58 ± 0.12 vs 0.93 ± 0.22 mmol/L; group B: 0.59 ± 0.11 to 0.8 ± 0.13 mmol/L). Furthermore, in group A2 the increase of phosphatemia was lower than in group A1.\u0000In conclusion, dietary approach supported by dietary counseling was effective in treating post kidney transplantation hypophosphatemia. The results of this pilot study might represent a useful working hypothesis for studies with a larger cohort of enrolled patients in order to confirm for these patients the efficacy of the nutritional approach and of the dietary counseling to post renal transplantation hypophosphatemia.","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88479977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intradialytic hypotension frequency is reduced by levocarnitine supplementation 补充左卡尼汀可降低分析性低血压的频率
Pub Date : 2022-08-31 DOI: 10.33393/gcnd.2022.2466
S. Aterini, A. M. Ciciani, F. Bergesio, Lorenzo Aterini, Barbara Vadalà, Marco Gallo
Introduction: Intradialytic hypotension (IDH) is a frequent complication of hemodialysis. IDH causes intradialytic discomfort and subclinical ischemia, resulting in a higher rate of morbidity and mortality. Levocarnitine (LC) administration has been suggested for the treatment of IDH, but conflicting reports about its efficacy have been published. We describe the effect of LC supplementation in patients experiencing recurrent IDH episodes, in spite of common strategies used to prevent it.Methods: Sixteen hemodialysis patients were studied. IDH was defined as a drop in systolic blood pressure ≥20 mmHg, with or without symptoms, prompting an intervention by the dialysis staff, such as reducing/stopping ultrafiltration rate and/or fluid administration. Blood pressure was recorded for 192 hemodialysis sessions, before LC supplementation. Thereafter LC (30 mg/kg dry weight) was administered at the beginning of each hemodialysis, registering blood pressure for 384 hemodialysis treatments. The difference between the predialysis systolic blood pressure and the minimum systolic blood pressure of each hemodialysis was evaluated (∆SBP), before and after LC supplementation. Cardiac ejection fraction was also measured.Results: Predialysis and postdialysis systolic, diastolic, and mean arterial pressures did not differ before and after LC supplementation. Before LC supplementation, 36 episodes of IDH occurred (19%), while after LC supplementation, the IDH episodes were 29 during 384 hemodialysis sessions (8%; χ2 = 16.03; p = 0.0001). ∆SBP was lower after LC supplementation, even though the difference was not significant (p = 0.22).Conclusion: IDH frequency was significantly reduced by predialysis LC supplementation, which can be helpful for patients’ well-being and reduction in IDH-associated risks.
导读:分析性低血压(IDH)是血液透析的常见并发症。IDH引起体内不适和亚临床缺血,导致较高的发病率和死亡率。左卡尼汀(LC)已被建议用于治疗IDH,但关于其疗效的相互矛盾的报告已发表。我们描述了LC补充在经历复发性IDH发作的患者中的效果,尽管常用的策略用于预防它。方法:对16例血液透析患者进行分析。IDH的定义是收缩压下降≥20 mmHg,伴有或无症状,促使透析人员进行干预,如降低/停止超滤率和/或给液。在补充LC之前,记录192次血液透析的血压。此后,在每次血液透析开始时给予LC (30 mg/kg干重),记录384次血液透析治疗的血压。比较补充LC前后透析前收缩压与每次血液透析最低收缩压的差值(∆SBP)。同时测量心脏射血分数。结果:透析前和透析后收缩压、舒张压和平均动脉压在补充LC前后没有差异。在补充LC之前,发生了36次IDH发作(19%),而补充LC后,在384次血液透析中,IDH发作29次(8%;χ2 = 16.03;P = 0.0001)。添加LC后,∆SBP较低,但差异不显著(p = 0.22)。结论:透析前补充LC可显著降低IDH发生频率,有助于改善患者健康,降低IDH相关风险。
{"title":"Intradialytic hypotension frequency is reduced by levocarnitine supplementation","authors":"S. Aterini, A. M. Ciciani, F. Bergesio, Lorenzo Aterini, Barbara Vadalà, Marco Gallo","doi":"10.33393/gcnd.2022.2466","DOIUrl":"https://doi.org/10.33393/gcnd.2022.2466","url":null,"abstract":"Introduction: Intradialytic hypotension (IDH) is a frequent complication of hemodialysis. IDH causes intradialytic discomfort and subclinical ischemia, resulting in a higher rate of morbidity and mortality. Levocarnitine (LC) administration has been suggested for the treatment of IDH, but conflicting reports about its efficacy have been published. We describe the effect of LC supplementation in patients experiencing recurrent IDH episodes, in spite of common strategies used to prevent it.\u0000Methods: Sixteen hemodialysis patients were studied. IDH was defined as a drop in systolic blood pressure ≥20 mmHg, with or without symptoms, prompting an intervention by the dialysis staff, such as reducing/stopping ultrafiltration rate and/or fluid administration. Blood pressure was recorded for 192 hemodialysis sessions, before LC supplementation. Thereafter LC (30 mg/kg dry weight) was administered at the beginning of each hemodialysis, registering blood pressure for 384 hemodialysis treatments. The difference between the predialysis systolic blood pressure and the minimum systolic blood pressure of each hemodialysis was evaluated (∆SBP), before and after LC supplementation. Cardiac ejection fraction was also measured.\u0000Results: Predialysis and postdialysis systolic, diastolic, and mean arterial pressures did not differ before and after LC supplementation. Before LC supplementation, 36 episodes of IDH occurred (19%), while after LC supplementation, the IDH episodes were 29 during 384 hemodialysis sessions (8%; χ2 = 16.03; p = 0.0001). ∆SBP was lower after LC supplementation, even though the difference was not significant (p = 0.22).\u0000Conclusion: IDH frequency was significantly reduced by predialysis LC supplementation, which can be helpful for patients’ well-being and reduction in IDH-associated risks.","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79707681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SGLT2 inhibitors: suggestions from the amphibian world SGLT2抑制剂:来自两栖动物世界的建议
Pub Date : 2022-07-25 DOI: 10.33393/gcnd.2022.2423
S. Michelassi
Sodium-glucose cotransporter 2 inhibitors are a class of antidiabetic drugs that inhibit glucose reabsorption in the proximal renal tubules. In many trials these drugs have shown unpredictable major cardio- and nephroprotective properties. Multiple hypotheses have been raised to elucidate the mechanisms underlying the last effects. Some authors suggest they may be due to the contemporary urinary loss of energy (as glucose) and water (by osmotic diuresis). This particular condition could induce metabolic changes resulting in more efficient energetics at cardiac and renal levels and in less oxidative stress. These changes might really be part of a series of evolutionarily conserved metabolic switches that allow organisms to survive in arid habitats with restricted nutrients and water availability, well studied in amphibians and collectively named “estivation”.
钠-葡萄糖共转运蛋白2抑制剂是一类抑制近端肾小管葡萄糖重吸收的降糖药物。在许多试验中,这些药物显示出不可预测的主要心脏和肾保护特性。已经提出了多种假设来阐明最后影响的机制。一些作者认为,这可能是由于当代尿中能量(如葡萄糖)和水分(通过渗透性利尿)的损失。这种特殊的情况可以诱导代谢变化,从而在心脏和肾脏水平上产生更有效的能量,并减少氧化应激。这些变化可能真的是一系列进化上保守的代谢开关的一部分,这些开关允许生物体在营养和水供应有限的干旱栖息地生存,在两栖动物身上得到了很好的研究,统称为“estivation”。
{"title":"SGLT2 inhibitors: suggestions from the amphibian world","authors":"S. Michelassi","doi":"10.33393/gcnd.2022.2423","DOIUrl":"https://doi.org/10.33393/gcnd.2022.2423","url":null,"abstract":"Sodium-glucose cotransporter 2 inhibitors are a class of antidiabetic drugs that inhibit glucose reabsorption in the proximal renal tubules. In many trials these drugs have shown unpredictable major cardio- and nephroprotective properties. Multiple hypotheses have been raised to elucidate the mechanisms underlying the last effects. Some authors suggest they may be due to the contemporary urinary loss of energy (as glucose) and water (by osmotic diuresis). This particular condition could induce metabolic changes resulting in more efficient energetics at cardiac and renal levels and in less oxidative stress. These changes might really be part of a series of evolutionarily conserved metabolic switches that allow organisms to survive in arid habitats with restricted nutrients and water availability, well studied in amphibians and collectively named “estivation”.","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81950882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Il ruolo del medico nella visione sanitaria olistica della salute 医生在整体健康观点中的作用
Pub Date : 2022-06-14 DOI: 10.33393/gcnd.2022.2430
Aurora Pianigiani, Francesco Romizi
na
{"title":"Il ruolo del medico nella visione sanitaria olistica della salute","authors":"Aurora Pianigiani, Francesco Romizi","doi":"10.33393/gcnd.2022.2430","DOIUrl":"https://doi.org/10.33393/gcnd.2022.2430","url":null,"abstract":"<jats:p>na</jats:p>","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75208840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstracts XXXX Congresso Nazionale SIAN ITALIA: L'evoluzione professionale e la formazione: ieri, oggi e domani - Rimini 9-11 Maggio 2022 意大利国家大会:职业发展与培训:昨天、今天和明天-里米尼,2022年5月9-11日
Pub Date : 2022-05-05 DOI: 10.33393/gcnd.2022.2410
{"title":"Abstracts XXXX Congresso Nazionale SIAN ITALIA: L'evoluzione professionale e la formazione: ieri, oggi e domani - Rimini 9-11 Maggio 2022","authors":"","doi":"10.33393/gcnd.2022.2410","DOIUrl":"https://doi.org/10.33393/gcnd.2022.2410","url":null,"abstract":"","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"84 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84318319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MMetformina e rene policistico dell’adulto: tra ricerca e impiego clinico mmetformin和多囊成人肾脏:在研究和临床应用之间
Pub Date : 2022-04-30 DOI: 10.33393/gcnd.2022.2398
Giovanni Piscopo
{"title":"MMetformina e rene policistico dell’adulto: tra ricerca e impiego clinico","authors":"Giovanni Piscopo","doi":"10.33393/gcnd.2022.2398","DOIUrl":"https://doi.org/10.33393/gcnd.2022.2398","url":null,"abstract":"","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"103 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78641963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Giornale di Clinica Nefrologica e Dialisi
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1